AGP Executive Report
Last update: 12 hours agoMars Exploration: China’s Tianwen-3 chief scientist says the mission’s top goal is finding signs of past life, with sample return targeted for about 2031 after a launch around 2028. Medical Science: A Phase 3 trial found AstraZeneca/Amgen’s Tezspire met key endpoints for eosinophilic esophagitis, and a Cambridge-led study reports low placental protein ISM2 could predict preeclampsia and fetal growth restriction. Biology & Health: Researchers mapped how SurA helps bacteria build antibiotic-resistant outer barriers, while new work links low-level GLP-1 use to slower biological aging signals. Space & Physics: Studies refine how supernovas make and spread titanium-44, and teams use AI to help CERN decide which collision data to keep. Tech & Society: Boston Scientific begins restoring shipping after a cyberattack, and the FDA recall flags fracture risk for unused spinal cord stimulator leads. Education: Minnesota MCA results show widespread science underperformance in multiple districts. Quirky Science: The 2026 Ig Nobels went to cockroach milk, nose-blowing, and other delightfully odd experiments.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
